Development of biomarkers for molecular target drugs

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


In general, the molecular target drugs were superior in the effect, less toxic and realized personalized medicine, resulting in progress in the cancer therapy. The rise in development cost of the molecular target drug and a decrease of the development efficiency become the problem of the drug industry recently. As the solution, development of the excellent biomarker associated with the drug development is considered to be the most important issue. Therefore, the development of the companion diagnostic agent which can evaluate the biomarker precisely is prosperous. A search of the biomarker and the simultaneous development of the companion diagnostic agent enter the mainstream of the development of new molecular target drug. Whereas the process of the drug development is complicated than before.

Original languageEnglish
Pages (from-to)1308-1312
Number of pages5
JournalNippon rinsho. Japanese journal of clinical medicine
Issue number8
Publication statusPublished - 2015 Aug 1


Dive into the research topics of 'Development of biomarkers for molecular target drugs'. Together they form a unique fingerprint.

Cite this